Drug Company Aims to Pool Genomic and Medical Data in Hunt for Rare Genetic Sequences Associated With Disease

Pune, India, 2023/MRFR Press Release/- Market Research Future published a Half Cooked research report on “Human Genetics Market Research Report - Global Forecast to 2032” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2032.

Human Genetics – Market Overview

The Human Genetics Market is anticipated to reach USD 65.18 Billion by 2032 at a 10.80% CAGR during the forecast period 2023-2032.

Genetics is the study of genes, their functions and their effects. Among the various types of genetics such as molecular genetics, developmental genetics, population genetics and quantitative genetics, human genetics is the study that deals with the inheritance occurs in human beings.

There are several growth influencer influencing industries growth such as:- advancement of genetics testing technologies, rising genetic diseases, and rising awareness in terms of increasing knowledge about the potential benefits in genetic testing. Furthermore, aging population and increasing incidence of cancer cases are the other factors propelling growth of human genetics market

Global Pharma giant Astra Zeneca launches project to sequence 2 million genomes. One of the world’s largest pharmaceutical companies has launched a massive effort to compile genome sequences and health records from two million people over the next decade. In doing so, AstraZeneca and its collaborators hope to unearth rare genetic sequences that are associated with disease and with responses to treatment.

To achieve that ambitious goal, AstraZeneca will partner with research institutions including the Wellcome Trust Sanger Institute in Hinxton, UK, and Human Longevity, a biotechnology company founded in San Diego, California, by genomics pioneer Craig Venter. AstraZeneca also expects to draw on data from 500,000 participants in its own clinical trials, and medical samples that it has accrued over the past 15 years

In doing so, AstraZeneca will be following a burgeoning trend in genetics research. For years, geneticists pursued common variations in human DNA sequences that are linked to complex diseases such as diabetes and heart disease. The approach yielded some important insights, but these common variations often accounted for only a small percentage of the genetic contribution to individual diseases. Researchers are now increasingly focusing on the contribution of unusual genetic variants to disease. Combinations of these variants can hold the key to an individual's traits. The hunt for important rare variants has led AstraZeneca to partner with the Institute for Molecular Medicine Finland

Human Genetics Market – Competitive Analysis

As the market seems to be attractive, growing and profitable, at the same time market has witnessed intense rivalry among existing competitors. There are many big players in the bilirubin blood test market such as: Agilent Technologies (U.S.), Bode Technology (U.S.), GE Healthcare (U.K.), Illumina (U.S.), LGC Forensics (U.K.), Orchid Cellmark, Inc. (U.S.), Promega Corporation (U.S.), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific, Inc. (U.S.)

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Human Genetics Market Research Report

Regional Analysis

The regional analysis includes North America, Europe, Asia Pacific, Middle East and rest of the world.

North America is dominating the Human genetic market due to increasing prevalence of diseases by genetic disorders and high technological advancement in the region.

Europe is the second largest market for Human Genetics, the rapid increase in viral infections such as Swine flues, cancer disease & various chronicle disease has increased the need of study of human genetic engineering

The Asian region is showing good opportunities in Human genetic market because of support provided by foreign countries for enhancing forensics and DNA profiling services. Apart from this, factors such as occurrence of large number of natural disasters and awareness through forensics and DNA profiling related conferences are expected to provide required impetus for the growth of this market